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Background: An acidic polysaccharide, fCS, from the sea cucumberHolothuria forskali has a range of biological activities.
Results: The conformation of fCS was determined, and resulting oligosaccharides were shown to retain desirable biological
properties.
Conclusion: The conformation of the fCS repeating unit underpins binding to L- and P-selectins.
Significance: Exploitation of the fCS-selectin interaction may open new avenues for therapeutic intervention using fCS frag-
ments or their mimetics.
Fucosylated chondroitin sulfate (fCS) extracted from the
sea cucumber Holothuria forskali is composed of the follow-
ing repeating trisaccharide unit: 33)GalNAc4,6S(134)
[FucX(133)]GlcA(13, whereX stands for different sulfation
patterns of fucose (X 3,4S (46%), 2,4S (39%), and 4S (15%)). As
revealed by NMR and molecular dynamics simulations, the fCS
repeating unit adopts a conformation similar to that of the Lex
blood group determinant, bringing several sulfate groups into
close proximity and creating large negative patches distributed
along the helical skeleton of the CS backbone. This may explain
the high affinity of fCS oligosaccharides for L- andP-selectins as
determined by microarray binding of fCS oligosaccharides pre-
pared by Cu2-catalyzed Fenton-type and photochemical depo-
lymerization. No binding to E-selectin was observed. fCS poly-
and oligosaccharides display low cytotoxicity in vitro, inhibit
human neutrophil elastase activity, and inhibit the migration of
neutrophils through an endothelial cell layer in vitro. Although
the polysaccharide showed some anti-coagulant activity, small
oligosaccharide fCS fragments hadmuch reduced anticoagulant
properties, with activity mainly via heparin cofactor II. The fCS
polysaccharides showed prekallikrein activation comparable
with dextran sulfate, whereas the fCS oligosaccharides caused
almost no effect. TheH. forskali fCS oligosaccharides were also
tested in a mouse peritoneal inflammation model, where they
caused a reduction in neutrophil infiltration. Overall, the data
presented support the action of fCS as an inhibitor of selectin
interactions, which play vital roles in inflammation and metas-
tasis progression. Future studies of fCS-selectin interaction
using fCS fragments or their mimetics may open new avenues
for therapeutic intervention.
Sea cucumbers have been used as a traditional tonic food in
many Asian countries for centuries, with themajor edible parts
being the body walls, which are predominantly composed of
collagen and acidic polysaccharides. Structurally, the acidic
bodywall polysaccharides of sea cucumbers can be described as
fucosylated chondroitin sulfates (fCS)6 (1–4) and sulfated
fucans (5, 6). In addition to being a culinary delicacy, sea
cucumbers have attracted considerable attention from
researchers because of a range of biological activities in fCS that
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can be isolated from their tissues in high yields. fCS isolated
from a variety of sea cucumbers were reported to possess anti-
coagulant (2, 7–14), antithrombotic (10, 15, 16), anti-inflam-
matory (17), anti-HIV (18–21), and metastasis blocking (22)
properties.
The fCS polysaccharides isolated from sea cucumbers have a
trisaccharide repeating unit with the following structure:
33)GalNAc(134) [Fuc(133)]GlcA(13. The 2-O posi-
tion of the glucuronic acid of the CS backbone repeating disac-
charide is consistently free of substitutions, whereas the 6-O
and 4-O positions of GalNAc can be either unsulfated or sul-
fated individually or simultaneously. The extent of GalNAc sul-
fation varies between species and/or different preparations; fCS
isolated from Ludwigothurea grisea (2, 16, 23) and Stichopus
japonicus (1, 24) contain 53 and 56% 6-O-sulfated species and
31 and 12% unsulfated GalNAc, respectively, whereas Yoshida
et al. (4) isolated fCS from S. japonicus containing 100%
GalNAc4,6S residues. Monofucosylation occurs invariably at
the 3-O position of the glucuronic acids. The existence of
extended fucose branches reported originally (23) has not been
confirmed by subsequent studies. The fucose side chain can be
either monosulfated (3-O or 4-O) or disulfated (2,4-O or 3,4-
O), and the degree and pattern of sulfation varies between spe-
cies (4, 8, 14, 16, 25).
The anticoagulant activity of fCS is linked with the presence
of both the fucose branches and the sulfation of themain disac-
charide repeating unit, as defucosylation or desulfation of the
polysaccharide leads to the loss of its activity (26). Sulfated
fucose on its own has no anticoagulant activity, and the posi-
tions of sulfates on both the CS backbone and the fucose side
chain determine the anticoagulant potency of fCS (7, 8, 14, 25,
27). Generally, the depolymerized fragments of fCS have signif-
icantly decreased anticoagulant activity (28, 29).
In addition to interacting with anticoagulant proteins, fCSs
also interact with the selectin family of cell adhesionmolecules.
fCS isolated from L. grisea is 4–8-fold more potent than hepa-
rin in inhibiting the interactions of P- and L-selectin with the
sialyl Lewis x (sLex) antigen. No inhibition of the interaction
with E-selectin was observed (22). It was also suggested that
attenuation of renal fibrosis in animal models by fCS is due to
their binding to P-selectins (30).
As the first step toward rationalizing the various biological
activities of fCS, we set out to determine the conformation of
fCS and compare it with the known three-dimensional struc-
tures of linear glycosaminoglycans (GAGs) (27, 31, 32). We
report here on the isolation of a GAG from the North Atlantic
sea cucumber Holothuria forskali and its identification as an
fCS by biochemical and biological analysis. In particular, we
present a three-dimensional structure of the repeating unit of
H. forskali fCS and show that (i) the conformation of the CS
backbone of fCS is very similar to that of CS-A, (ii) fucose is
stacked above the GalNAc residue of the preceding trisaccha-
ride repeating unit in a manner seen between the fucose and
galactose of the Lex blood group trisaccharide, (iii) this arrange-
ment is not affected by the sulfation pattern of fucose, and (iv)
the resulting conformation creates a large concentration of
negative charges on the surface of fCS. Using neoglycolipid-
based oligosaccharide microarrays (33–35) we demonstrate
strong binding of fCS oligosaccharides to L- and P-selectins. In
addition, we report on the anticoagulant activity, prekallikrein
activation, in vitro cell-based activity, and in vivo neutrophil
recruitment of the H. forskali fCS and its fragments generated
by two depolymerization methods.
EXPERIMENTAL PROCEDURES
Extraction and Purification of fCS—Individual samples of
H. forskali were collected off the west coast of Scotland near
Oban. The body wall of at least six individuals was separated
from other components and used for GAG extraction. Extrac-
tionwas carried out by amodification of previousmethods (23).
An equal volume of water was added to the tissue, and it was
proteolytically digested overnight using alcalase (2.5L DX,
Novozymes) at 1:100 (v/v), pH 8–9, and 60 °C. The resultant
liquor was filtered and mixed with one-tenth volume of anion
exchange resin (LEWATIT VPOC 1074/S6328A, 1:1 (v/v))
overnight. The resin was washed in water, and the boundmate-
rial was eluted with 1 or 5 MNaCl and precipitated with 0.4 or 2
volumes of ethanol. The precipitates were air-dried, resus-
pended, dialyzed against water using 8-kDa MWCO tubing
(BioDesign Inc.), and freeze-dried.
The four separated fractions were analyzed by HPLC-size
exclusion chromatography using a Waters Alliance 2695 sys-
tem (Waters (Manchester, UK) with refractive index and pho-
todiode array detectors and a BioSep4000 column (300  7.8
mm, Phenomenex), calibrated with dextran standards (Fluka
12, 25, 50, 80, 270, and 670 kDa), and equilibrated in 50 mM
Tris-HCl, pH 7, 1mM EDTA, and 0.9%NaClmobile phase. The
uronic acid content was estimated by the carbazole reaction
(36) and sulfation by a modified sulfate assay (37). These anal-
yses indicated that only the 5 M NaCl 0.4-volume fraction was
dominated by a highly sulfated component (30% sulfate by
molecular weight and30% uronic acid content), which likely
represented a GAG-like molecule (Table 1). Therefore, this
fraction was further separated on a Sepacore preparative chro-
matography system (Buchi) usingQ-Sepharose anion exchange
resin (GE Healthcare) in an XK26/20 column. Gradient elution
was carried out using 50mMNaCl, 50mMTris-HCl, pH 7.5, 2 M
NaCl, and 50 mM Tris-HCl, pH 7.5, running over 60 min with
monitoring at A214 nm and conductivity. All peaks were col-
lected, dialyzed (as above), and freeze-dried before repeating
the above biochemical analysis. From this analysis amajor peak
eluting at 1.3–1.4 M NaCl was identified as likely containing a
GAG-like molecule (30% sulfate by molecular weight and
30% uronic acid content). Therefore it was selected for sub-
sequent biochemical and biological analysis. Five repeat extrac-
tion batches confirmed the reproducibility of the described
procedure (Table 1).
Monosaccharide and Disaccharide Composition Analysis—
Monosaccharide composition of the Q-Sepharose late-eluting
fraction and of the Cu2-catalyzed Fenton-generated depo-
lymerized fragments (see below for preparation) was deter-
mined using a Shimadzu GC-2014 with flame ionization detec-
tion and ZB5-ms column. The samples (10 l of a 10 mg/ml
solution in water, dehydrated, washed with methanol, and
dehydrated again) were subjected to methanolysis by the addi-
tion of 100l of 0.5 Mmethanolic-HCl (Supelco) at 85 °C for 4 h
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in heat-treated Reacti-VialsTM. This was followed by re-N-
acetylation of free amines with the addition of 20 l of neat
acetic anhydride. Samples were dried, washed inmethanol, and
redried before the addition of 40 l of neat trimethylsilane re-
agent (Supelco), mixing, and subsequent GC analysis. Mixed
monosaccharide standards (5 nmol each) of arabinose, xylose,
rhamnose, fucose, mannose, glucose, galactose, glucuronic
acid, galacturonic acid, N-acetylgalactosamine, and N-acetyl-
glucosamine (all Sigma) were run together with 5 nmol of
scyllo-inositol (Sigma) as an internal control, which was also
added to all samples to enable calculation of a standard ratio.
Disaccharide analysis was carried out on the Q-Sepharose
fraction by digestion of a 1-mg of sample (100 l of a 10 mg/ml
solution in water) using either chondroitinase ABC lyase (12.5
milliunits/l in 0.1 M ammonium acetate at 37 °C overnight) or
heparinase II (both from Grampian Enzymes) (7 milliunits/l
in 5 mM Tris-HCl, pH 7, 50 mM NaCl, 0.1 mg/ml BSA at 25 °C
overnight). The resulting digest was analyzed by HPLC-IEC
using aWatersAlliance 2695 systemwith a ProPac PA1 column
(4  250 mm, Dionex), running a water, pH 3.5/2 M NaCl, pH
3.5, gradient elution and photodiode array detection at 232 nm
(38). Chondroitin (Di-0S, Di-4S, Di-6S, UA2S, Di-Se, Di-Sd,
Di-Sb, or Di-TriS) or heparin (IVA, IVS, IIA, IIIA, IIS, IIIS, IA,
or IS) disaccharide standards (Dextra Laboratories) were used,
and chondroitin sulfate or heparin (Sigma)was run as a control,
as well as no-enzyme controls for all samples.
NMR Spectroscopy—EDTA and trimethylsilylpropionate
(TSP) were purchased from Goss Scientific Instruments Ltd.
and Aldrich, respectively. The samples were dissolved in 540l
of 99.9% D2O containing deuterated 10 mM NaH2PO4 
HNa2HPO4 (Sigma) buffer (pH 7.2) to which 20 l of a stock
solution of EDTA and TSP solution were added. The stock
solution was prepared by dissolving 4 mg of EDTA and 9 mg of
TSP in 200 l of the phosphate buffer. The pH was adjusted to
7.2 by adding few drops of a concentrated solution of NaOH in
D2O. All spectra were acquired at 50 °C on an 800MHzAvance
I (Bruker) NMR spectrometer equippedwith a z-gradient triple
resonance TCI cryoprobe. The spectra were referenced using
1H and 13C signals (0 ppm) of TSP.
13C one-dimensional NMR spectra were acquired using
relaxation and acquisition times of 1.5 and 0.682 s; 14,080 scans
were accumulated in 9 h per spectrum. FIDs (free induction
decays) were zero-filled once, and a 2-Hz exponential line
broadening was applied prior to Fourier transformation. Two-
dimensional 1H-13CHSQC spectra were acquired using T1 and
T2 acquisition times of 22 and 107 ms, respectively; 20 scans
were acquired into each of 800 F1 complex data points, result-
ing in the total experimental times of 7 h/sample. The standard
two-dimensional HSQC-TOCSY Bruker pulse sequence was
modified by appending a 1H spin echo with an overall duration
of 1/1JCH (optimized for a 1JCH 150Hz) after the TOCSY spin
lock, and two two-dimensional 1H-13C HSQC-TOCSY spectra
were acquired in an interleaved manner. The first spectrum
with the 180° 13C pulse was applied simultaneously with the
180° 1H pulse of the final spin echo and the second onewithout.
This resulted in a change of the sign of one-bond cross-peaks
between the two spectra. The addition of the two two-dimen-
sional matrixes prior to processing yielded a two-dimensional
HSQC-TOCSY spectrumwith substantially reduced one-bond
cross-peaks. Such treatment facilitated the identification of
weak TOCSY cross-peaks. Each two-dimensional HSQC-
TOCSY spectrum was acquired using T1 and T2 acquisition
times of 22 and 106 ms, respectively; 800 complex data points
using 24 scans were collected in F1 in each experiment; the total
duration of onemeasurement was 18 h. Spin-lock was achieved
via a DIPSI-2 mixing sequence applied for 25 ms. Two-dimen-
sional 1H-13C, two-dimensional 1H-13CHSQC-NOESY spectra
were acquired using T1 and T2 acquisition times of 21 and 106
ms, and 750 complex data points were collected in F1 using 192
scans. The total duration of the experiment was 66 h. The
NOESY mixing time was set to 25 ms.
Molecular Dynamic Simulations—The initial three-dimen-
sional structures of the fCS oligosaccharides were generated
using the Carbohydrate Builder available on the GLYCAM
Website. The templates generatedwere prepared formolecular
dynamics (MD) simulation using the tLEaP module of AMBER
2014. AllMD simulationswere performed using theCUDA (39,
40) implementation of PMEMD in the AMBER 14 software
suite (41). The carbohydrate parameters were taken from
GLYCAM06j (42).
Prior toMDsimulation, energyminimizationwas performed
in implicit solvent (43) with Cartesian restraints (100 kcal/mol/
Å2) on all residues. After such minimization, the system was
solvated with explicit TIP3P water and reminimized in 5000
steps of steepest descent followed by 5000 steps of conjugate
gradient using a nonbonding cutoff of 10.0 Åwith no restraints.
The minimization steps were followed by a heating phase,
during which the system was brought from 5 to 300 K over
50 ps. Finally, a production simulation of 50 ns was performed
in the isothermal-isobaric ensemble, where the first 200 ps of
the simulation were considered as the equilibration phase and
excluded from subsequent analyses. Molecular graphics and
TABLE 1
Summary of biochemical data for fractions collected during the extraction process
Fractions % Sulfate Uronic acida Mass/kDa main peakb % Area of main peak
S.D. mg/ml S.D. S.D.
1 M 0.4vol 14 (6.2, n 4) 0.71 (n 2) 12 (n 3) 80.4 (25.2, n 3)
1 M 2 vol LOQc (n 4) 0.45 (n 2) 12 (n 4) 100 (0, n 4)
5 M 0.4 vol 33 (2, n 3) 0.54 (n 2) 140 (11.5, n 3) 93.9 (7.5, n 3)
5 M 2 vol 18.7 (3.5, n 4) 0.67 (n 2) 12 (n 3) 100 (0, n 3)
5 M 0.4 vol QS peak (1.4 M NaCl)d 33.4 (3, n 5) 0.56 (0.05, n 5) 137.9 (8.8, n 5) 95 (10.7, n 5)
a Carbazole method.
bMass estimation based on HPLC-SEC with a dextran standard curve using refractive index detection.
c Lower limit of quantification (LOQ) of method is 3.8% sulfate.
dQS, Q-Sepharose.
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analysis of the simulation results were performed with the
UCSF Chimera package (44).
Depolymerization of the fCS Polysaccharide—The intact
polymer was subjected to depolymerization using two different
methods. The first was a Fenton-type free radical process using
hydrogen peroxide and a copper catalyst that has been used
previously to depolymerize fCS (45, 46). The native polymer
(200 mg) was added to a reaction flask containing 100 ml of
water. Copper acetate monohydrate was added to give a final
concentration of 20 mM, and the reaction was heated to 60 °C
and stabilized at pH 7 by the addition of sodium hydroxide.
Hydrogen peroxide (2%) was pumped into the vessel at a rate of
22.5 ml/h to give a final peroxide:fCS ratio of 3.5 after a 90-min
reaction time. These conditions generated oligosaccharide
fragments of the desired target size. The reaction was main-
tained at pH 7 by the use of a pH control unit and sodium
hydroxide. After depolymerization, excess copperwas removed
by Chelex (Sigma), and copper bound to the polymer was
exchanged for sodiumusingQ-Sepharose (GEHealthcare) pre-
parative chromatography in anXK26/20 columnwith 5 MNaCl
as the eluent. Two size ranges of fragmentswere prepared using
size exclusion preparative chromatography on a Superdex 30
(GE Healthcare) in an XK16/100 column with water as the
mobile phase. These fragments were subjected to biochemical
and biological analysis, as described above for the extraction
process, to confirm the identity and evaluate any chain length-
dependent biological effects. A list of samples and identifiers is
shown in Table 2.
The fCS polysaccharide was also depolymerized using a
novel photochemical-based method (47). fCS (300 mg) was
added to water (30 ml) in a shallow crystallizing dish. 0.1% tita-
nium(IV) oxide anatase powderwas added, and aUV light (125-
watt low pressure mercury lamp) was placed over the vessel as
closely as possible to maximize UV absorbance by the titanium
oxide. The reaction was left stirring for 3 days and was moni-
tored by HPLC (Waters) using a Superdex peptide 10/300 GL
(GE Healthcare) column. Fragments were separated using Bio-
Gel P-10 resin (Bio-Rad Laboratories) for size exclusion chro-
matography using two XK26/100 columns and an XK26/20
guard column (GE healthcare). Their sizes were estimated
using dermatan sulfate (DS) oligosaccharides (dp2–dp8, where
dp is degree of polymerization) prepared by enzymatic depo-
lymerization. The sample integrity was confirmed by NMR.
The samples and identifiers are listed in Table 2.
Mass Spectrometry—Negative ion electrospray mass spec-
trometry of P-fCS-dp3 and P-fCS-dp4 was carried out on a
Waters Synapt G2-S instrument. The oligosaccharide fractions
were desalted on a gel filtration column Superdex peptide and
eluted with ammonium acetate (0.05 mM). After removal of the
volatile salt by repeated lyophilization, the sample was dis-
solved in water for analysis.
Preparation of Neoglycolipids (NGLs) and Detection of Selec-
tin Binding by Microarray Analysis—The different fCS oligo-
saccharides used for selectin binding studies are shown inTable
2. Their concentration was determined by quantitation of hexu-
ronic acid in a carbazole assay (36). Oligosaccharides from each
fraction (50 nmol) were conjugated to amino-oxy-functional-
ized DHPE (Sigma) to generate NGLs by oxime ligation as
described (33). Where indicated, groups of NGLs were subfrac-
tionated by semipreparative TLC (48). The following NGLs were
usedascontrols: lacto-N-neotetraose,Gal(134)GlcNAc(133)
Gal(134)Glc, 3-sialyllacto-N-fucopentaose II (SA(3)-LNFP-
II), NeuAc(233)Gal(133)[Fuc(134)]GlcNAc(133)Gal
(134)Glc, 3-sialyllacto-N-fucopentaose III (SA(3)-LNFP-III),
(NeuAc(233)Gal(134)[Fuc(133)]GlcNAc(133)Gal
(134)Glc (all from Dextra Laboratories), and CS-C hexasaccha-
ride:	UA(133)GalNAc6S(134)GlcA(133)GalNAc6S-
(134)GlcA(133)GalNAc6S (49).Thesewereprepared fromthe
reducing oligosaccharides by reductive amination with DHPE
(48).TheNGLsofP-fCS-dp3,P-fCS-dp4andP-fCS-dp6were sep-
arated into upper and lower subfractions by prepara-
tive TLC using HPTLC plates with aluminum backing (5 m,
Merck) and the solvent system chloroform/methanol/water
60/35/8 (by volume). The NGL probes, 13 total, were roboti-
cally printed in duplicate on nitrocellulose-coated glass slides at
two levels (2 and5 fmol/spot) (34).TheE-, P-, andL-selectinswere
analyzed as culture supernatants of IgM chimeras (50) at a 1/3
dilution, and their binding was detected with biotinylated anti-
human IgM (Vector Laboratories) followed by Alexa
Fluor-647-labeled streptavidin (Molecular Probes) at 1 g/ml.
The results, shown in Fig. 4, are representative of at least four
analyses.
Anticoagulant Activity—Characterization of the anticoagulant
activity of native fCS and the depolymerized fragments was per-
formed using an automated coagulometer (Instrumentation Lab-
oratories, Warrington, UK). Plasma-based methods included the
European Pharmacopeia assay method for heparin sodium (01/
2008:20705) and a secondmethod, the activated partial throm-
boplastin time (APTT) assay. These two plasma methods dif-
fered, as the European Pharmacopeia method used sheep
plasma (First Link Ltd.) and the second used human pooled
plasma (National Blood Transfusion Service, UK). Antithrom-
bin-dependent anti-factor Xa and anti-factor IIa assays were
performed in accordance with the United States Pharmaco-
poeia monograph for heparin sodium (USP 34-NF 29), factor
Xa from Diagnostic Reagents Ltd. (Oxfordshire, UK), and anti-
thrombin and thrombin from the National Institute for Biolog-
ical Standards and Control (NIBSC, UK). Heparin cofactor II
(HCII, Enzyme Research Laboratories, Swansea, UK)-depen-
dent inhibition of factor IIa was carried out by replacing anti-
thrombin with HCII in the USP monograph method for anti-
factor IIa activity. Potencies were assigned using parallel line
TABLE 2
Identifiers of H. forskali fCS and fCS oligosaccharide samples used in
this study
F, Fenton-type depolymerization; P, photochemical depolymerization; dp, degree of
polymerization (an average polymer length).
Chemical and biological
analysis
Selectin binding
experiments
fCS (full-length polysaccharide) F-fCS-dp10a
F-fCS-dp20b F-fCS-dp6a
F-fCS-dp9b P-fCS-dp10a
P-fCS-dp10a P-fCS-dp6c
P-fCS-dp6a P-fCS-dp4c
- P-fCS-dp3c
a Fractionated on Bio-Gel P-10.
b Fractionated on Superdex 30.
c Fractionated on Bio-Gel P-10, separated into upper and lower fractions.
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analysis against either the Sixth International Standard for
Unfractionated Heparin (07/328, NIBSC, UK) or the Second
International Standard for Low Molecular Weight Heparin
(LMWH).
Prekallikrein (PK) Activation—To further investigate the
interaction of fCS with the contact activation pathway and
inflammation, a PK activation assay was carried out. A dilution
series of the samples (the native H. forskali fCS, F-fCS-dp20,
and F-fCS-dp9 at 1.5–100 g/ml) and a dextran sulfate (Leu-
conostoc mesenteroides, Sigma) positive control was set up, and
each of the seven doses was mixed with normal pooled plasma
(George King Bio-Medical Inc.) (51). After a 5-min activation
period at 37 °C, a chromogenic substrate specific for plasma
kallikrein was added (Chromogenix S2302), and color develop-
ment, indicating substrate cleavage, was measured after 4 min
(A405–490 nm). The change in absorbance was compared with a
blank control related to the amount of kallikrein in the blood
resulting from PK activation by test samples. Four runs were
carried out, and a concentration-response curve was generated
for each sample.
In Vitro Cell-based Activity—The cytotoxicity of H. forskali
fCS, F-fCS-dp20, and F-fCS-dp9 was examined by measuring
their effects on the metabolic activity of a BHK cell line (ham-
ster kidney fibroblast, ECACC 85011433) cultured in Glasgow
minimum essential medium with tryptase (Sigma), glutamine
(GE Healthcare), and fetal calf serum (FCS) (Sigma). Triplicate
wells of cells and samples (0.1mg/ml)were incubated overnight
at 37 °C in a 96-well plate, andmetabolic activity was measured
using CellTiter-Glo luminescent reagent (Promega) and a Syn-
ergy II plate reader (BioTek). Fucoidan (0.1 mg/ml, Marinova)
and doxorubicin (0.01 and 0.001 mg/ml, Sigma) were run as
assay controls, and % viability was calculated based on compar-
ison with an untreated control.
The effect of the isolated fCS and of F-fCS-dp20 and F-fCS-
dp9 oligosaccharides on neutrophil elastase activity was mea-
sured by incubation with freshly isolated human neutrophils.
Test samples and a fucoidan control (0.1 mg/ml) were mixed
with freshly isolated neutrophils, 5 g/ml cytochalasin B
(Sigma), and 10 ng/ml TNF (Merck) and incubated for 30min
at 37 °C. 100 ng/ml fMLP (Sigma) was then added, and cells
were further incubated for 45 min. Cells were removed by cen-
trifugation and the supernatants mixed with 0.05 mg/ml elas-
tase substrate (Merck) in triplicate wells of a 96-well micro-
plate. A kinetic read was carried out on a Powerwave HT plate
reader (BioTek) with measurements taken at 405 nm every 5
min for 1 h andVmax calculated for each sample. Elastase activ-
ity, given as %, was calculated by comparison with an untreated
control.
The effect of the isolated fCS on themigration of neutrophils
in vitrowasmeasured using a chemotaxis assay. Human umbil-
ical vein endothelial cells (PromoCell) were grown to 80% con-
fluency on a 3-m-pore Transwell insert in a 24-well tissue
culture plate (Greiner), using PromoCell growth medium.
Human umbilical vein endothelial cells were prestimulated
with 0.01 g/ml IL1 (Sigma) and 0.01 g/ml TNF (Merck)
for 6 h. Freshly isolated human neutrophils stained with 2.5
g/ml calcein (Sigma) and test compounds (1–100g/ml)were
added above the membrane, and 100 ng/ml IL-8 (Sigma) was
added below (in duplicate wells). After a 50-min incubation the
Transwells were removed, and the number of calcein-labeled
cells in the lower compartment were measured using a Synergy
2 plate reader (BioTek) at 485/528 nm. The % migration was
calculated by comparison with an IL-8 only control.
Peritoneal Inflammation Model—To investigate the effect of
H. forskali fCS on neutrophil recruitment to the peritoneal cav-
ity ofmice, a protocol was used based onMoffat et al. (52).Male
BALBcmice (6–8 weeks, 20–22 g) were randomized to receive
an intravenous injection of either saline control or test oligo-
saccharide (F-fCS-dp20 at 75 and 7.5 mg/kg and F-fCS-dp9 at
52 and 5.2mg/kg) (5 animals/test group). 15min after the intro-
duction of vehicle or test saccharide, zymosan A (Sigma) was
injected intraperitoneally to give a total dose of 1 mg/mouse.
After 4 h mice were sacrificed, and 3 ml of saline was injected
into the peritoneal cavity. The cavity wasmassaged, and 2ml of
lavage fluid was collected and stored on ice. The total and dif-
ferential cells were enumerated to determine the effects of oli-
gosaccharides on cell infiltration at the two doses tested.
RESULTS
fCS from H. forskali—The extraction of GAGs from the
H. forskali body wall resulted in the isolation of a 95% pure
peak by anion exchange chromatography (5 M 0.4-volume
Q-Sepharose peak, Table 1). Biochemical analysis of this peak
estimated it to be a highly sulfated molecule between 120 and
140 kDa (by HPLC-size exclusion chromatography using dex-
tran standards). This is almost certainly an overestimation of
molecular weight because of the difference in structure
between standards and sample, but it provides a means of
assessing batch-to-batch reproducibility at the extraction stage.
A small amount of protein co-eluted with the fCS as indicated
by the presence of small CH3 signals around1.1 ppm in the 1H
NMR spectrum (Fig. 1a). This impurity was not present in the
depolymerized material.
Monosaccharide analysis of two preparations of thismaterial
suggested a composition of 7% rhamnose, 50% fucose, 2%
galactose, 9% glucuronic acid, 30%N-acetylgalactosamine, and
2% galacturonic acid, strongly indicative of a fCS-likemolecule.
The low glucuronic acid content was likely due to the well doc-
umented limitations of acidic hydrolysis of GAGs (53), which
can result in underestimation of the uronic acid content
because of its resistance to hydrolysis or potential destruction
when liberated. Equally other nonresistant components pres-
ent in low amounts were probably overestimated (2% galactose,
galacturonic acid, and 7% rhamnose) by thismethod, as they are
not detectable by NMR. Nevertheless, the monosaccharide
analysis provided strong evidence for a fucosylated GAG. No
disaccharides were generated after chondroitinase ABC lyase
or heparinase II enzymatic digestion of this peak, indicating
that the product was resistant to digestion by these enzymes.
Primary Structure of the fCS Determined by NMR—Struc-
tural heterogeneity of the fCS isolated from H. forskali became
evident from the inspection of its one-dimensional 1H spec-
trum (Fig. 1a). This spectrum contained three signals assignable
to the anomeric protons of fucose, indicating different sulfation
patterns of this residue. Nevertheless, it was possible to determine
the primary structure of this polysaccharide through self-consis-
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tent analysis of two-dimensional 1H-13CHSQC, two-dimensional
1H-13C HSQC-TOCSY, and two-dimensional 1H-13C HSQC-
NOESY 800-MHz spectra as 33)GalNAc4,6S(134)[FucX
(133)]GlcA (13. The X signifies the different sulfation pat-
terns of fucose. On the other hand, only the 4,6-disulfation was
found for the GalNAc residues. The three fucose sulfation pat-
terns referred to as fCS I–III, are Fuc3,4S (I, 46%), Fuc2,4S (II,
39%), and Fuc4S (III, 15%) and represent the only heterogeneity
of this fCS. The obtained 1H and 13C chemical shifts for all three
forms are summarized in Table 3. Except for a constant differ-
ence of 2–2.5 ppm in the 13C spectrum caused by different
referencing, these were remarkably consistent with those pub-
lished previously by Yoshida et al. (4), who identified an fCS in
the S japonicus sea cucumber, albeit with different ratios for
sulfation patterns I–III. There is also a broad agreement of
NMR data on fCS with a more recent work by Chen et al. (7).
Conformation of the Repeating fCSTrisaccharide Is Very Sim-
ilar to That of the Lex Trisaccharide—During the analysis of a
two-dimensional 1H-13C HSQC-NOESY spectrum of H. for-
skali fCS, unusual cross-peaks were noticed between the pro-
tons of GalNAc and the fucose rings of fCS I (Fig. 1). The short
interproton distances that gave rise to these cross-peaks indicates
that the fucose residue is stacked on top of the GalNAc, as shown
inFig. 1b.This conformation is reminiscentof theconformationof
the Lex blood group determinant as determined by x-ray crystal-
lography (54) and NMR spectroscopy (55). The Lex trisaccha-
ride, Gal(134)[Fuc(133)]GlcNAc, is not dissimilar from that
of the repeating unit of the fCS, 33)GalNAc4,6S(134)[FucX-
(133)]GlcA(13. The differences in the primary structure
between Lex and fCS trisaccharides and the lack of sulfates in Lex
indicate that this rigid conformation is a consequence of similar car-
bohydrate scaffolds present in both species, i.e. similarmonosaccha-
ridescomposition, identicalglycosidic linkages, andanomericconfig-
urations, and is not disrupted by the sulfates of fCS.
The Ring Stacking Is Independent of the Sulfation Pattern—
The same pattern of NOE peaks was also observed for fCS II,
implying that the change of fucose sulfation from 3,4S to 2,4S
did not affect the conformation of the trisaccharide fragment.
The population of fCS III was too low to allow observation of
NOE peaks in the 13C-edited NOESY experiment. Neverthe-
less, a credible indirect support for the existence of this confor-
mation irrespective of the nature of the sulfation pattern came
from the comparison of 1H chemical shifts of fucose (Table 3).
The chemical shift ofH-5was particularly informative. In blood
FIGURE1.a, 800MHz 1HNMRspectrumofH. forskali fCS.b, conformationof fCS I, highlighting theGalNAc/fucoseprotons showing inter-residueNOEs (H-2/H-5
(purple), H-6/H-3 (yellow), H-6/H-4 (black), and H-2/H-6 (red)), as well as the distance (green) between fucose H-5 and the oxygen involved in the
GalNAc4,6S(134)GlcA glycosidic bond in both fCS I and fCS II. c and d, expansions of an overlay of the two-dimensional 1H-13C HSQC (red) and the
two-dimensional 1H-13C HSQC-NOESY (blue) spectra. The inter-residue NOE cross-peaks are circled. The methyl resonances of proteins are marked by an
asterisk.
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group B trisaccharide, in which fucose is linked to O-2 of galac-
tose, the H-5 resonates at 4.16 ppm, whereas in the Lex (the
O-3-linked fucose) it is found at 4.84 ppm. The latter value was
practically identical to theH-5 chemical shifts (4.79–4.89 ppm)
in fCS I–III. The large deshielding of this proton is caused by
stacking of the fucose residue on top of the preceding mono-
saccharide. The chemical shift of 4.73 ppm reported for the
hydrolysis resistant part of L. grisea fCS (2) is also elevated. As
this fCS contains primarily GalNAc6S and very little of the
GalNAc4,6S species, we concluded that the stacking of fucose
and GalNAc residues does not depend on the level of the Gal-
NAc sulfation either.
It is interesting to note that a large chemical shift for fucose
H-5 was also observed in the Lea trisaccharide (56) in which
fucose is (134)-linked, whereas Gal is (133)-linked. Thus,
despite swapping of the two linkages between Lex and Lea, Fuc
and Gal are in juxtaposition in both trisaccharides (57, 58).
Molecular Dynamic Simulations of fCS I and II Oligo-
saccharides—The experimentally determined stacking of Fuc
and GalNAc was also shown by MD using the GLYCAM06j
force fieldwithAMBER14. Such orientationwas present 95%of
the time for the MD simulation of fCS dodecasaccharides, fCS-
dp12 (supplemental Figs. 1S and 2S and Table 1S). The distances
between protons showing inter-residue NOEs were consistent
with NMR data. The dihedral angles of Fuc(133)GlcA link-
ages were within 10° of those seen in an x-ray structure of Lex
(54) or a NMR solution structure of Lex (59). The dihedral
angles of GlcA(133)GalNAc and GalNAc (134)GlcA
linkages were within 20° of the NMR solution structure of a CS
pentasaccharide (60), desulfated CS hexasaccharide (61), or a
CS tetrasaccharide in complex with chondroitinase B. The
geometry of aGalNAc (134)GlcA linkagewasmarkedly dif-
ferent from that of the x-ray structures of a CS fiber, which,
however, is different from the values predicted by the exo-ano-
meric effect (62). This is likely caused by the presence of Ca2
and/or crystal packing (63) of the x-ray structure. An inspection
of the dihedral angles associated with the sulfate groups (sup-
plemental Fig. 3S) showed that, with the exception of GalNAc
C-6 sulfate, the orientation of the sulfate groups is relatively
restrained, forming a well defined cluster of negative charge.
In summary, MD and NMR analysis revealed that fCS main-
tains the conformation of CS-A with fucose branches arranged
in a Lex manner (Fig. 2), and a high level of sulfation does not
alter this conformation. As a consequence, the four sulfates of
the repeating fCS trisaccharide are brought to close proximity,
FIGURE 2. Closest to average structures generated by MD simulations of 2,4 Fuc- (a) and 3,4 Fuc-sulfated fCS (b). The insets show an expansion of the
respective trisaccharide repeating units.
TABLE 3
1H and 13C chemical shifts (ppm) of fCS from H. forskali fCS and 1H
chemical shifts of fucose-containing trisaccharidesa
a The chemical shift of H5 of fucose is highlighted in bold; see “Results” for
discussion.
b See Ref. 68.
c See Ref. 84.
d See Ref. 2.
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forming a large negative patch. This is the case for both sulfa-
tion patterns of fucose (fCS I and II).
The similarities in the conformation of fCS and that of Lex
(Lea) known to bind selectins prompted us to investigate the
interaction of fCS with selectins. It is plausible that the rigid
conformation common to these molecules and the subsequent
spatial proximity of four sulfates are behind the binding of fCS
to selectins (22). To study this interaction and the basic biolog-
ical properties of fCS, oligosaccharides of fCS were prepared.
Depolymerization of the fCS—Fenton-type Cu2-catalyzed
depolymerization using H2O2 radicals produced two size
ranges of polymers; one averaged 6 kDa and the other 2.5 kDa,
both estimated by HPLC-size exclusion chromatography using
heparin standards. These sizes corresponded approximately to
a 20-mer (F-fCS-dp20) and a nanosaccharide (F-fCS-dp9) con-
taining 7 and 3 trisaccharide repeating units of fCS, respec-
tively (Table 2). The photochemical depolymerization method
also produced oligosaccharides of a similar size or smaller,
compared with those generated by the Fenton-type method.
Those used in this study were characterized, using DS oligosac-
charide standards, as tri- to decasaccharides (P-fCS-dp3 to
P-fCS-dp10) (Table 2). Using sulfated GAGs such as heparin or
DS as molecular weight standards is potentially problematic
when estimating the molecular weights of branched fCS oligo-
saccharides. We therefore determined the molecular weight of
P-fCS-dp3 and P-fCS-dp4 fractions by MS and were able to
confirm their correct classification (see below and Fig. 3). This
is likely because the fucose branch is tightly packed against the
main polysaccharide chain (Figs. 1 and 2).
The NMR analysis of P-fCS-dp3 and P-fCS-dp4 fractions (data
not shown) indicated some structural heterogeneity, particularly
associatedwith the fucose residue, whichwas likely because of the
different sulfation patterns of this residue. The trisaccharide frac-
tion contained only reducing end GlcA, implying the presence of
GalNAc4,6S (134)[FucX(133)]GlcA trisaccharide. These
data were corroborated by electrospraymass spectrometry with a
trisaccharide composition of GalNAc, GlcA, and Fuc (molecular
ion [M-2H]2
 at 350.7 (Fig. 3)).
Higher fractions are heterogeneous in sequence. In the case of
the tetrasaccharide fraction P-fCS-dp4, an additional monosac-
charide residue can be either aGlcA orGalNAc ([M-2H]2
 at 438.6
or 452.1), and the sequence can be either GlcA(133)GalNAc
(134) [Fuc(133)]GlcA or GalNAc(134)[Fuc(133)]
GlcA(133) GalNAc. Themolecular ions detected byMS con-
tained only 2–3 sulfate groups instead of the expected 4–6
groups. Inspection of the two-dimensional 1H-13CHSQC spec-
tra of these fractions confirmed the presence of signals of sul-
fated residues, indicting some loss of sulfates during the MS
experiments. In addition, both depolymerization processes lead
to the opening of a proportion of the reducingGalNAc ring and
formation of the galactosaminic acid by further oxidation, as
evidenced also by the additional oxygen identified by MS (Fig.
3), similar to glucosaminic acid in heparin depolymerization
reported previously (64, 65). Albeit heterogeneous, these oligo-
saccharides were considered suitable for initial selectin binding
studies.
Binding of Selectins to fCS Oligosaccharides inMicroarrays—
The fractions of H. forskali oligosaccharide fragments were
converted into NGLs (33). During the purification process of
NGLs it became apparent that each fraction containedmultiple
components, mainly because of a different degree of sulfation,
in accord with the NMR and MS analyses above. The NGLs of
P-fCS-dp3, P-fCS-dp4, and P-fCS-dp6 were separated into
upper and lower subfractions by preparative TLC (Fig. 4).
F-fCS-dp6 and F-fCS-dp10 fractions were also included in this
study (see Table 2). Fig. 4 shows the results of the microarray
analysis. In the present study, each oligosaccharide fractionwas
arrayed at two levels, 2 and 5 fmol/spot in duplicate. The bind-
ing strengths with the glycan probes immobilized at the two
densities were dose-dependent. Several conclusions could be
drawn from the data: (i) all fCS oligosaccharide fractions were
bound by P- and L-selectins, whereas none was bound by E-se-
FIGURE 3.Negative ion electrospraymass spectra of the tri- and tetrasaccharide fractions.
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lectin; (ii) signals elicited by all of the fCS fractions were stron-
ger with L-selectin than with P-selectin; (iii) in both instances
the binding intensities of the P-fCS-dp3-L fraction were com-
parable with those of larger oligosaccharide fractions. This sug-
gests that the fCS trisaccharide unit, structurally similar to a Lex
trisaccharide, retains the affinity for P- and L-selectins. The
lower apparent affinities of the tetrasaccharide and higher oli-
gosaccharide fractions for selectins could be related to their
heterogeneity not only in degree of sulfation but also in mono-
saccharide sequence (see above).A quantitative ranking of the
binding strengths as a function of the chain length is therefore
not possible at this point; (iv) fCS oligosaccharides were bound
muchmore strongly by P- and L-selectins than SA(3)-LNFP-II
and SA(3)-LNFP-III, which were included as positive controls,
and the CS-C hexasaccharide, which lacks fucose. In a previous
assay (data not shown) using P- and L-selectins a heparin
14-mer showed binding signals 2 times higher than SA(3)-
LNFP-II and SA(3)-LNFP-III. This is in linewith the inhibition
of binding assays reported previously (66), which showed that
heparin is a stronger binder of selectins. Our data therefore
suggest that fCS oligosaccharides include components that are
bound by P- and L-selectins with higher affinities than heparin
or sLex (sLea), and the fCS trisaccharide fraction contains com-
ponents with comparable, even superior, binding compared
with the longer species.
Following themicroarray and the structural work, we further
characterized the biological properties of the fCS polysaccha-
ride and its oligosaccharides by standard biophysical and bio-
chemical methods in vitro and in vivo. These data aimed to
complement similar existing information on fCS polysaccha-
rides isolated from a variety of sea cucumber species.
Anticoagulant Activities of H. forskali fCS—The estimated
specific anticoagulant activities (in IU/mg) for H. forskali fCS
are listed inTable 4. Antithrombin-dependent activities against
both thrombin and factor Xa are very low, with activity at less
than 1 IU/mg, whereas HCII-mediated activity is much higher,
at 120 IU/mg, in keepingwith that previously reported for these
types of molecule (67). Clotting-based assays give values of 131
IU/mg in sheep plasma and 68.9 IU/mg in human plasma. In
comparison, the fCS oligosaccharides derived by Fenton-type
Cu2-catalyzed or photochemical depolymerization showed an
overall reduction from the parent fCS polysaccharide activity in
all assays. The photochemically depolymerized fragments
retain a higher anticoagulant activity than the chemically depo-
lymerized fragments; P-fCS-dp10 APTT is 72.5 IU/mg, and
F-fCS-dp9 APTT is 23.7 IU/mg (Table 4). HCII activity is more
FIGURE 4. Microarray analyses of the binding of human L-, P-, and E-selectins with NGLs derived from H. forskali fCS oligosaccharides. The results
shown are the means of the fluorescent intensities of duplicate spots at 2 and 5 fmol/spot with error bars. The insets in the L- and P-selectin panels are an
expansion of the fluorescence signals of the control probes 1–4 in relation to the fCS hexasaccharide probes 9, 10, and 12.The asterisks indicate measured
values that are off-scale. The details of fCS oligosaccharides are shown in Table 1, and sequences of the control NGLs are given under “Experimental Proce-
dures.” High performance TLC of NGL fractions of P-fCS-dp3, -dp4, and -dp6 (S, solvent front; O, origin) is shown on the bottom right.
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heavily reduced than APTT-based activity when the fCS is
depolymerized; for example F-fCS-dp20 has a 15-fold decrease
inHCII-mediated activity and only a 1.5-fold decrease byAPTT
measurement. Heparin (a normal clinical grade unfractionated
heparin (NIBSC code 0/7/330) has the same level of activity in
all the anticoagulant assays used. Oversulfated chondroitin sul-
fate (OSCS), purified from contaminated heparin (NIBSC code
SS104), has the same activity profile as fCS except in the anti-
thrombin-dependent assays. Here the contaminating heparin
present in this OSCS sample caused higher readings. In the
APTT and HCII assays the samples gave concentration-re-
sponse curves parallel to that of the unfractionated heparin
international standard, indicating that they behave in the same
way as this standard when potency is estimated by these meth-
ods. However, when using the antithrombin methods this was
not the case, and samples did not test parallel to the unfraction-
ated or LMWH standards.
PK Activation—H. forskali fCS and the oligosaccharides
F-fCS-dp20 and F-fCS-dp9were tested to assess their effects on
the contact pathway by measuring PK activation. At doses
above 12.5 g/ml, the native fCS caused a large increase in
plasma kallikrein, indicative of PK activation, which was com-
parablewith that generated by a dextran sulfate positive control
(Fig. 5). However, incubation of plasma with the fCS oligosac-
charides caused almost no kallikrein increase at any of the seven
concentrations tested, indicating that they did not cause PK
activation. No standard or reference data were available, so the
values presented are absolute.
In Vitro Cell-based activity of fCS and Its Fragments—The
H. forskali fCS polysaccharide exhibited minimal cytotoxicity
in a BHK cell viability assay at 100 g/ml, with a cell viability of
87.5% (n 5) as compared with an untreated control (Table 5).
The depolymerized fragments also showed minimal effects on
cell viability under these conditions with 93% (n  6) cell
viability (Table 5). The fCSwas found to reduce human neutro-
phil elastase activity at the same concentration by70% (Table
5). This could be either via a mechanism involving direct inhi-
bition of the elastase enzyme or by inhibition of elastase release
from the neutrophils. Human neutrophil elastase was also
strongly inhibited by the depolymerized fragments with84%
inhibition (n  6) (Table 5). F-fCS-dp20 oligosaccharides
showed greater enzyme inhibition than the F-fCS-dp9 fraction,
suggesting that chain lengths less than 6 kDa are less effective
inhibitors. The native fCS was found to inhibit migration of
neutrophils through an endothelial cell monolayer in a concen-
tration-dependentmanner,with70% inhibition at 100g/ml,
50% at 10 g/ml, and 10% at 1 g/ml (Table 5).
Peritoneal Inflammation—The H. forskali fCS oligosaccha-
rides were tested in a mouse peritoneal inflammation model.
The stimulatory agent zymosan A caused a significant increase
in neutrophil recruitment to the peritoneal cavity over controls,
74% (SD  4%) and 79% (SD  22%) in the two assay groups
(Fig. 6). F-fCS-dp20 caused a significant inhibition (p0.05)
of neutrophil recruitment to the peritoneal cavity at the lower
dose of 7.5mg/kg, amounting to27% inhibition (Fig. 6a). The
FIGURE5.ActivationofPKbyH. forskali fCSandfCSoligosaccharides.The
elevatedOD represents the increasing presence of kallikrein in blood plasma,
which is directly correlated with PK activation. Dextran sulfate, a known PK
activator, was included for comparison. The nativeH. forskali fCS polysaccha-
ride caused activation similar to that seenwith dextran sulfate, but the oligo-
saccharides F-fCS-dp9 and F-fCS-dp20 did not activate PK at these
concentrations.
TABLE 4
Estimated anticoagulant and antithrombotic potency values for H. forskali fCS
Values are in IU/1 mg of sample, with 95% confidence limits in parentheses. All were tested against the 6th International Standard for Unfractionated Heparin (07/328),
except for the HCII assay, which was tested against the 2nd International Standard for LMWH (01/608). OSCS and heparin values are shown for comparison. EP, European
Pharmacopeia; NIBSC, National Institute for Biological Standards and Control; USP, United States Pharmacopoeia; AT, antithrombin; LOD, limit of detection; F,
Fenton-type depolymerization; P, photochemical depolymerization; dp, degree of polymerization (an average polymer length).
Sheep plasma (EP)
APTT
Human plasma (NIBSC)
APTT
USP anti-Xa
(AT-dependent)
USP anti-IIa
(AT-dependent) HCII (NIBSC)
Native fCS 131 (125–136) 68.9 (67.2–70.6) 0.40 (0.38–0.43) 0.56 (0.53–0.59) 120 (112–129)
F-fCS-dp20 89.5 (82.4–97.4) 24.4 (22.9–26.0) 0.46a (0.43–0.49) LOD 7.8 (6.6–9.5)
F-fCS-dp9 23.7 (21.9–25.6) 6.3 (6.1–6.6) 0.181a (0.176–0.185) LOD 0.65 (0.54–0.77)
P-fCS-dp10 72.5 (70.1–75.0) 51.4 (49.5–53.3) 1.10a (0.92–1.30) LOD 13.6b (12.3–15.0)
P-fCS-dp6 21.0 (15.7–28.1) 7.70c (7.43–7.98) 0.28a (0.26–0.29) LOD 0.96b (0.90–1.03)
OSCS 214 (207–222) 46.3 (45.2–47.3) 27.1 (25.6–28.9) 13.9 (13.2–14.7 201 (188–215)
Heparin 199 (189–209) 199 (193–204) 203 (187–219) 196 (176–218) 206 (197–216)
a Samples did not test parallel to the standard, indicating that they did not behave in the same manner.
b Samples tested well against the LMWH standard.
c The sample did not test well against the standard.
TABLE 5
Summary of in vitro biological activity ofH. forskali fCS and fragments
F-fCSdp9 and F-fCSdp20
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higher F-fCS-dp20 dose (75 mg/kg) and both doses of F-fCS-
dp9 (5.2 and 52 mg/kg (Fig. 6b)) also caused a similar degree of
inhibition of cell migration but did not achieve statistical sig-
nificance. For comparison, a dexamethasone phosphate posi-
tive control tested under the same conditions resulted in a 42%
(SD  16%; not shown) inhibition of migration (although p 
0.059, thus just missing significance). The native fCS was also
tested in thismodel under the same conditions, but it was found
to have strong anticoagulant effects, and therefore the experi-
ments were not pursued further.
DISCUSSION
A polysaccharide isolated from the sea cucumber H. forskali
was identified as an fCS and investigated in terms of biochem-
ical and biological activity and by structural analysis usingNMR
spectroscopy. The biochemical characterization of the mole-
cule by HPLC-size exclusion chromatography, sulfate assay,
and monosaccharide and disaccharide analyses, all provided
evidence for an fCS-like molecule, which was confirmed by
NMR. Themost surprising finding of the structural elucidation
of fCS was the intermolecular NOE correlations observed in
fCS, which revealed structural similarities of the branched tri-
saccharide repeating unit of fCS with the well characterized
branched trisaccharide of the Lex blood antigen determinant.
We have demonstrated that the 3-O-GlcA-attached fucose of
the fCSs trisaccharide repeating units is stacked above the
GalNAcmonosaccharide in amanner similar to that seen in the
Lex, where the fucose is positioned above the Gal residue (54,
55). This is despite obvious differences in the primary structure
of both carbohydrates.
Recently, an unconventional C-H…O bond between the H-5
of fucose of Lex and O-5 of galactose was found by theoretical
calculations to have a large stabilizing effect on such a confor-
mation (68). The existence of this H-bond is supported by the
elevated experimental chemical shifts of the H-5 of fucose in
both of Lex and fCS trisaccharide. Combined with van der
Waals interactions, this could be the reason for stabilizing such
conformation independently of the sulfation pattern ofGalNAc
or fucose and could potentially explainwhy both species bind to
selectins.Nevertheless, thedensityof thenegativecharge is impor-
tant for selectinbinding, andhighly sulfated linearGAGshave also
been shown to bind to selectins. For example, affinity and kinetic
analyses using surface plasmon resonance revealed that the over-
sulfated CS/DS chains containing GlcA(133)GalNAc4,6S
disaccharide units bind to L- and P-selectins with high affinity
(KD 21.1–293 nM). A CS tetrasaccharide containing two
GalNAc4,6S residues also bound tightly to the selectins (69). In
addition, the binding of sLex to P-selectin is much enhanced
when this tetrasaccharide is part of a glycopeptide containing
one or more tyrosine sulfate residues such as found in the
PSGL-1 polypeptide (70, 71).
What are the underlying structural features of the fCS-selec-
tin interaction? It is possible that the tight conformation of the
fCS trisaccharide repeating unit, and the subsequent formation
of a large negative patch, causes fCS to interact strongly with the
two selectins. To determine whether this is the case, atomic reso-
lution data of the fCSL-/P-selectin complexes are required. Such
data will also likely answer the question why structurally related
E-selectin does not bind fCS or other sulfated GAGs such as hep-
arin, whereas it does bind sLex/a.
Because of the structural similarities between the fCS trisac-
charide repeating unit and sLex, as well as the existing literature
on the binding of fCS polysaccharides with P- and L-selectins
(22), small oligosaccharides were prepared from fCS and tested
for selectin binding. As demonstrated by our NGL microarray
FIGURE 6. Effects of H. forskali fCS oligosaccharides on zymosan-stimulated neutrophil recruitment to mouse peritoneal cavity (100% vehicle
zymosan; 5 animals/test group). The dexamethasone phosphate positive control tested under the same conditions exhibited 42% inhibition (16%)with a
p valueof 0.059 (not shown).a, effect of F-fCS-dp20on zymosan-stimulatedneutrophil recruitment indicatedan inhibitory effect at bothdosesbut significance
only in the lower dose (*, p 0.05). b, effect of F-fCS-dp9 on zymosan-stimulated neutrophil recruitment indicated non-significant inhibitory effects at both
doses.
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analysis, there is a size-independent (up to dp10) tight binding
of the small H. forskali fCS oligosaccharides to P- and L-selec-
tins. This tight binding could explain the ability of fCS to inhibit
selectin-Ig binding to immobilized PAA-sLex as observed pre-
viously (22). The blocking in vitro by fCS of the migration of
human neutrophils through a vascular endothelial cell layer is
supportive of the selectin binding studies, suggesting that this
effect may have biological relevance, as observed for other
GAGs (72, 73). This is also supported by our in vivo studies,
which indicate that fCS oligosaccharide causes modest inhibi-
tion of zymosan-stimulated neutrophil migration into the
mouse peritoneal cavity, likely to be through a selectin binding
mechanism.
Even though the binding of the smaller fCS oligosaccharides
(dp3–dp10) to selectins based on the microarray analysis
appears to be size-independent, at least some of the biological
activities of the native molecule are chain length-dependent. A
reduction in polymer size appears to enhance elastase inhibi-
tion activity, although this effect is reversed once chain length
drops below a critical size, possibly around 10 units. Con-
versely, anticoagulant activity is gradually lost as size decreases.
An alternative interpretation for the decreased anticoagulation
is a partial desulfation during the depolymerization process, but
NMR analysis of the fragment generated by us, together with
the data from the literature (45), indicate that this is not the case
and the free radical depolymerization maintains the levels of
sulfation of the native polymer. This is important, as it has been
shown that the anticoagulant activity of fCS depends in part on
the overall sulfation levels (28). NMR analysis of the photo-
chemically depolymerized fCS oligosaccharides indicates a
high degree of preservation of the original structural features.
This provides further confidence that the biological activity
observed is not due to any modifications resulting from the
depolymerization process.
This apparent size and sulfation pattern-dependence of the
anticoagulant activity of fCS is similar to that of other GAGs.
The observation that with decreasing fCS polymer size, elastase
inhibition activity is retained, but that anticoagulant activity is
much reduced, could be of value in some therapeutic applica-
tions where anti-inflammatory effects are desirable but where
anticoagulant activity would be unwanted. It could also reduce
the adverse effects associated with the use of long, highly sul-
fated polysaccharide chains (74) as demonstrated in LMWH
(75).
The anticoagulant action of the fCS polysaccharide has some
similarities with OSCS, including sensitivity to the species ori-
gin (sheep or human) of the plasma used in the APTT assay
(Table 4). The anticoagulant action of fCS is driven by potenti-
ation of the HCII inhibition of thrombin, and there is no anti-
coagulant action mediated through antithrombin. This is sim-
ilar to the response to OSCS, although the presence of heparin
in this preparation gave a higher anti-thrombin-mediated
activity. The depolymerized fragments of fCS have a marked
reduction in HCII activity but retain, relatively speaking, a
higher anticoagulant activity when measured by APTT. As this
higher activity cannot be attributed to the potentiation of HCII
inhibition (or antithrombin potentiation), there must be an
alternative anticoagulant mechanism occurring. There is
another observed pathway that is HCII-independent, where
fCS acts by inhibiting factor X, through binding to the factor
IXa-factor VIIIa complex (13), and factor XII (76).
The relative importance of the two anticoagulation pathways
is debatable; Nagase et al. (13) suggest that the inhibition of
factor X is of major importance for fCS hemostatic effects,
whereas Fonseca et al. (9) report that fCS acts mainly through
HCII but shows reduced anticoagulant activity when tested
with antithrombin as the inhibitor and factor Xa as the target
protease. This latter report is supported by the data presented
in our current study. Experiments in rats have also shown dif-
ferences in the plasma coagulation activity when the animals
are injected intravenously with fCS or mammalian GAGs such
as DS or LMWH (67).
Thus, it seems that the mechanisms of the anticoagulant
activity of linear GAGs such as heparin, DS, or OSCS are differ-
ent than that exhibited by branched sulfated polysaccharides
such as fCS. This is likely to be a consequence of the differences
between conformations of linear and branched GAGs, under-
pinned by different carbohydrate scaffolds and accentuated by
specific distributions of the larger number of sulfate groups
available. These factors may modulate the specificity and the
strength of the interaction of GAGs with different proteins of
the anticoagulation pathway, resulting in different biological
properties of linear and branched sulfated GAGs.
It is interesting to note that in the case of HCII-dependent
activity, the sulfation pattern of the fucose residue of fCS plays
a major role in the activity of the polysaccharide, with Fuc2,4S
exhibiting significantly higher anticoagulant activity than
Fuc3,4S (8). On the other hand, in the case of HCII-indepen-
dent binding, the sulfation pattern of the fucose of fCS does not
affect the anticoagulant activity of the polysaccharide (7).
The structural similarities of the H. forskali fCS polysaccha-
ride and the OSCS (the presence of the CS-E repeating disac-
charides), together with similar anticoagulant activity profiles
of these compounds, suggested that fCS may have the same
pro-inflammatory effects as OSCS via the contact system/
kinin-kallikrein pathway (77–79). Measurements of plasma
kallikrein in an activation assay supported this theory by show-
ing that the native polymer clearly causes PK activation at a
level similar to dextran sulfate, although the shorter chain oli-
gosaccharides do not. As the activation of PK is likely due to the
high negative charge of the molecule, which allows it to form
the required complex of PK, high molecular weight kininogen,
and factor XII, it is presumed that the smaller oligosaccharide
fragments do not carry a high enough net charge or size to
enable complex formation, and thus no activation of PK takes
place. This is in keeping with the other assays carried out in this
study in that the native fCS has significantHCII activity, is toxic
in vivo, and activates PK, whereas the fragments have no or
minimal HCII activity, are non-toxic, have a mild anti-inflam-
matory effect in vivo, and do not activate PK.
The fCS polysaccharide and selected oligosaccharides were
tested for their in vitro biological activities. Similar to the data
observed for many GAGs, they displayed a low level of toxicity
and inhibited the activity and/or the release of human neutro-
phil elastase (80–82). The fCS polysaccharide also inhibited
themigration of human neutrophils through an endothelial cell
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layer in vitro, suggesting that it had properties similar to hepa-
rin-like GAGs (72) as well as other identified fCS (22).
In conclusion, the analysis of the fCS extracted from the sea
cucumber H. forskali showed the presence of three different
sulfation patterns of fucose, similar to those isolated from other
sea cucumber species thus far. In addition, our NMR and MD
studies showed that the repeating trisaccharide unit of fCS
adopts a unique conformation in solution, similar to that of Lex
blood group trisaccharide determinant, whereas the backbone
maintains the conformation of CS. As a direct consequence of
this conformation, several sulfate groups of fCS are brought
together forming a large negative patch. This, in combination
with a rigid Lex-like conformation, may explain the high-affin-
ity binding of fCS oligosaccharides to L- and P-selectins, which
was established experimentally in microarray binding assays.
Although further targeted work with purified fCS oligosac-
charides is required, the data presented in this study indicate
that they are non-toxic in vitro, have low anticoagulant activity,
do not activate prekallikrein, show some inhibition of the
human neutrophil elastase activity, inhibitmigration of neutro-
phils in vitro through an endothelial cell layer, and retain strong
binding to L- and P-selectins. Atomic resolution data of the
fCSL-/P-selectin complexes are required to characterize this
high-affinity binding in detail. Overall our data support of the
action of fCS as an inhibitor of selectin interactions, which play
vital roles in inflammation, the progression of metastasis, and
potentially also in anti-HIV activities. It is also intriguing to
note that the human dendritic lectin (DC-SIGN), involved in
HIV entry, is able to bind Lex (83), and therefore the anti-HIV
properties of fCS could be linked to the competitive binding of
the two molecules. Studies of fCSselectin binding currently
underway in our laboratorywill thus hopefully open theway for
amultitude of therapeutic interventions using fCS fragments or
their mimetics.
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